A Critical Assessment of Exosomes in the Pathogenesis and Stratification of Parkinson’s Disease
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Extracellular vesicles including exosomes are released by a variety of cell types including neurons and exhibit molecular profiles that reflect normal and disease states. As their content represents a snapshot of the intracellular milieu, they could be exploited as biomarkers of the otherwise inaccessible brain microenvironment. In addition they may contribute to the progression of neurodegenerative disorders by facilitating the spread of misfolded proteins at distant sites or activating immune cells. This review summarizes recent advances in the study of exosomes in Parkinson’s disease pathophysiology and their potential as disease biomarkers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ngolab, J., Trinh, I., Rockenstein, E., Mante, M., Florio, J., Trejo, M., Masliah, D., Adame, A., Masliah, E., & Rissman, R. A. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0445-5 · Cited by 200
RetractedKowal, J., Arras, G., Colombo, M., Jouve, M., Morath, J. P., Primdal-Bengtson, B., Dingli, F., Loew, D., Tkach, M., & Théry, C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521230113 · Cited by 3,426
Li, J.-Y., Englund, E., Holton, J. L., Soulet, D., Hagell, P., Lees, A. J., Lashley, T., Quinn, N. P., Rehncrona, S., Björklund, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1746 · Cited by 1,845
Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease
Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B., & Olanow, C. W. (2008) · Nature Medicine · doi:10.1038/nm1747 · Cited by 1,722 · cited 1×
“This is especially relevant to recent evidence that -synuclein propagation along brain regions may account for disease progression: LB pathology was identified in embryonic neural grafts 12–16 years after transplantation into the brains of people with PD [22, 23] and in transgenic mice, human -synuclein can transit to…”
BackgroundInclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485 · cited 1×
“This is especially relevant to recent evidence that -synuclein propagation along brain regions may account for disease progression: LB pathology was identified in embryonic neural grafts 12–16 years after transplantation into the brains of people with PD [22, 23] and in transgenic mice, human -synuclein can transit to…”
BackgroundRamirez, A., Heimbach, A., Gründemann, J., Stiller, B., Hampshire, D., Cid, L. P., Goebel, I., Mubaidin, A. F., Wriekat, A.-L., Roeper, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1884 · Cited by 1,208
α-Synuclein strains cause distinct synucleinopathies after local and systemic administration
Peelaerts, W., Bousset, L., Van der Perren, A., Moskalyuk, A., Pulizzi, R., Giugliano, M., Van den Haute, C., Melki, R., & Baekelandt, V. (2015) · Nature · doi:10.1038/nature14547 · Cited by 1,130 · cited 1×
“-Synuclein pathology in the brain was also demonstrated following the systemic administration of -synuclein assemblies [28].”
BackgroundEmmanouilidou, E., Melachroinou, K., Roumeliotis, T., Garbis, S. D., Ntzouni, M., Margaritis, L. H., Stefanis, L., & Vekrellis, K. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5699-09.2010 · Cited by 1,115 · cited 2×
“Initial studies in SY5Y cells expressing -synuclein showed that both monomeric and oligomeric forms of synuclein are released both free in the medium and within exosomes the latter in a process that was calcium-dependent [10].”
BackgroundResultPrion-like spreading of pathological α-synuclein in brain
Masuda-Suzukake, M., Nonaka, T., Hosokawa, M., Oikawa, T., Arai, T., Akiyama, H., Mann, D. M. A., & Hasegawa, M. (2013) · Brain · doi:10.1093/brain/awt037 · Cited by 867
Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease
Shi, M., Liu, C., Cook, T. J., Bullock, K. M., Zhao, Y., Ginghina, C., Li, Y., Aro, P., Dator, R., He, C., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1314-y · Cited by 676 · cited 5×
“Although our own unbiased proteomic approach in total exosome fractions based on ultracentrifugation did not identify -synuclein enrichment in the serum of PD patients [54], immunoprecipitation and characterization of neuronspecific exosomes in plasma using the neuronal adhesion molecule L1CAM showed that exosomal -sy…”
BackgroundMethodInfluential
Cited by
Bidirectional Microglia–Neuron Communication in Health and Disease
Szepesi, Z., Manouchehrian, O., Bachiller, S., & Deierborg, T. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00323 · Cited by 459
“However, in the late stage of the disease, microglial MVs have been found responsible for the transportation and distribution of soluble toxic proteins like Aβ and α-synuclein peptides, and to promote the spread of the disease (Benilova et al., 2012; Tofaris, 2017; Croese and Furlan, 2018; Zhang S. et al., 2018).”
BackgroundSerum neuronal exosomes predict and differentiate Parkinson’s disease from atypical parkinsonism
Jiang, C., Hopfner, F., Katsikoudi, A., Hein, R., Catli, C., Evetts, S., Huang, Y., Wang, H., Ryder, J. W., Kuhlenbaeumer, G., et al. (2020) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-322588 · Cited by 275
Self-citationThe Role of Immunosenescence in Neurodegenerative Diseases
Costantini, E., D’Angelo, C., & Reale, M. (2018) · Mediators of Inflammation · doi:10.1155/2018/6039171 · Cited by 133
“Many authors evaluate the α-synuclein secretion outside or within exosomes [121, 122].”
α‐Synuclein in Plasma‐Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's Disease
Stuendl, A., Kraus, T., Chatterjee, M., Zapke, B., Sadowski, B., Moebius, W., Hobert, M. A., Deuschle, C., Brockmann, K., Maetzler, W., et al. (2021) · Movement Disorders · doi:10.1002/mds.28639 · Cited by 108
“One possible route is the transfer of α-synuclein with extracellular vesicles (EVs).(16,17) EVs are small vesicles 40–180 nm in diameter that are released by many cell types and serve various functions, including clearance of superfluous or toxic cellular content and cell–cell communication.”
BackgroundFacile Impedimetric Analysis of Neuronal Exosome Markers in Parkinson’s Disease Diagnostics
Fu, Y., Jiang, C., Tofaris, G. K., & Davis, J. J. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c03092 · Cited by 74
Self-citation
Metadata
- Authors
- Tofaris, G. K.
- Venue
- Journal of Parkinson’s Disease
- Publisher
- SAGE Publications
- Published
- 2017-09-11
- Volume
- 7
- Issue
- 4
- Pages
- 569-576
- ISSN
- 1877-7171 (ISSN-L)
- 1877-718X
- OpenAlex
- W2754066003
- Cited by
- 88
- References
- 14
- FWCI
- 3.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Critical Assessment of Exosomes in the Pathogenesis and Stratification of Parkinson’s Disease. https://app.cochat.ai/papers/10.3233/jpd-171176
- The paper
- Tofaris, G. K. (2017). A Critical Assessment of Exosomes in the Pathogenesis and Stratification of Parkinson’s Disease. Journal of Parkinson’s Disease. https://doi.org/10.3233/jpd-171176
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.